Adjuvant treatment in biliary tract cancer

Biliary tract cancers (BTCs) are a heterogeneous group of malignancies with a dismal prognosis. Despite radical surgery, the five-year overall survival (OS) does not exceed 40% in the best series. Adjuvant treatments are widely used even though they have mainly been investigated in small retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Palloni, Andrea, Frega, Giorgio, De Lorenzo, Stefania, Rizzo, Alessandro, Abbati, Francesca, Deserti, Marzia, Tavolari, Simona, Brandi, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798763/
https://www.ncbi.nlm.nih.gov/pubmed/35117108
http://dx.doi.org/10.21037/tcr.2018.08.17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798763/
https://www.ncbi.nlm.nih.gov/pubmed/35117108
http://dx.doi.org/10.21037/tcr.2018.08.17

Ejemplares similares